Holzkirchen, Germany, 31-1-2014 — /EuropaWire/ — Sandoz announced today it has received Romanian marketing authorization for AirFluSal® Forspiro®, an innovative new inhaler for patients with asthma and COPD. The product was first approved in Denmark on December 18th, 2013. The new product … Read the full press release
London, UK, 23-10-2013 — /EuropaWire/ — GlaxoSmithKline plc (LSE:GSK) today announced the submission of a New Drug Application (NDA) in the US for the once daily inhaled corticosteroid (ICS) treatment, fluticasone furoate (FF), administered using the ELLIPTA™ dry powder inhaler. The NDA … Read the full press release
Posted in Government, Healthcare, Pharma & Biotech, Science, United Kingdom
Tagged asthma, Bradd Pavur, Catherine Hartley, David Daley, David Mawdsley, ELLIPTA™, ELLIPTA™ dry powder inhaler, fluticasone furoate (FF), fluticasone furoate monotherapy, Gary Davies, GlaxoSmithKline, GlaxoSmithKline plc, GSK, James Dodwell, Jeff McLaughlin, Juan Carlos Molina, Karen Collins, Kirsty Collins (SRI & CG), LSE:GSK, Lucy Singah, Melinda Stubbee, NDA, New Drug Application (NDA), once daily inhaled corticosteroid (ICS) treatment, Simon Steel, Stephen Rea, Tom Curry, US FDA, US regulatory submission, Ziba Shamsi
12-8-2013 — /EuropaWire/ — Research led by University of Leicester health expert aims to speed up impact for patients across the region Issued by Nottinghamshire Heathcare NHS Trust on 9 August 2013 A collaboration between the NHS and universities across the … Read the full press release
Posted in Education, Financial, Healthcare, Science, United Kingdom
Tagged asthma, Ather Mirza, Diabetes, East Midlands patients, mental health issues, NIHR CLAHRC East Midlands, Nottinghamshire Healthcare, Primary Care Diabetes, Professor Kamlesh Khunti, Professor Khunti, Professor Mike Cooke, University of Leicester health reseach, Vascular Medicine, £28.4M funding
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?